Volume 99, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Yemen is a country that has been treating severe cases of oncho-dermatitis since 1992 and is now moving to a program aimed at the elimination of the transmission of . It is important to ensure that the currently acceptable tools used in epidemiological assessment of onchocerciasis in Africa and Latin America also apply to Yemen. Five hundred and ten blood samples from three known –endemic areas, locations that have never been under a mass treatment program, were tested for the presence of antibodies against a panel of –specific antigens using enzyme-linked immunosorbent assay (Ov16) and luciferase immunoprecipitation system (Ov-FAR-1 and Ov-MSA-1) assays. Overall, 31.4% of the samples tested were positive, with positivity increasing with age. Positivity was seen in 76.5% of those presenting with clinical onchocerciasis but importantly also in more than 28.5% of those defined as free of oncho-dermatitis; these latter individuals are likely to be serving as a source for persistent reinfection. This study supports the use of the current –specific serologic methodology in Yemen.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Fawdry AL, 1957. Onchocerciasis in south Arabia. Trans R Soc Trop Med Hyg 51: 253256.
    [Google Scholar]
  2. Al-Qubati Y, 1994. The first use of ivermectin for treatment of onchocerciasis in Yemen. Trans R Soc Trop Med Hyg 88: 343.
    [Google Scholar]
  3. Al-Kubati AS, Mackenzie CD, Boakye D, Al-Qubati Y, Al-Samie AR, Awad IE, Thylefors B, Hopkins A, 2018. Onchocerciasis in Yemen: moving forward towards an elimination program. Int Health 10: i89i96.
    [Google Scholar]
  4. Büttner DW, von Laer G, Mannweiler E, Büttner M, 1982. Clinical, parasitological and serological studies on onchocerciasis in the Yemen Arab Republic. Tropenmed Parasitol 33: 201212.
    [Google Scholar]
  5. Mackenzie CD, Homeida MM, Hopkins A, Lawrence JC, 2012. Elimination of onchocerciasis from Africa: possible? Trends Parasitol 28: 1622.
    [Google Scholar]
  6. WHO, 2016. Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human onchocerciasis. Criteria and Procedures. Geneva, Switzerland: World Health Organization, 1–44. ISBN: 978 92 4 151001 1. WHO/HTM/NTD/PCT/2016.1.
  7. Golden A et al., 2016. A recombinant positive control for serology diagnostic tests supporting elimination of Onchocerca volvulus. PLoS Negl Trop Dis 10: e0004292.
    [Google Scholar]
  8. Burbelo PD, Leahy HP, Iadarola MJ, Nutman TB, 2009. A four-antigen mixture for rapid assessment of Onchocerca volvulus infection. PLoS Negl Trop Dis 3: e438.
    [Google Scholar]
  9. Mackenzie CD, Boakye D, Hopkins A, 2012. A National Plan for the Elimination of onchocerciasis from the Republic of Yemen. Sana’a, Yemen: Ministry of Public Health and Population, the Republic of Yemen.

Data & Media loading...

  • Received : 19 Jan 2018
  • Accepted : 08 Apr 2018
  • Published online : 06 Aug 2018
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error